Related Experiment Video
Updated: Apr 6, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
[DNA methylation in thyroid carcinoma]
Abstract:
Cancer has become clear that not merely gene variations but also epigenetic modifications may contribute to it. Epigenetic changes refer to stable alterations in gene expression with unrelated to changes in the underlying genetic sequence,resulting in heritable. DNA methylation is one of the common epigenetic changes. It control the gene expression through changing DNA conformation and stability, chromatin structer, DNA-protein interaction. The reversal of dysregulated DNA methylation has emerged as a potential strategy for the treatment of thyroid carcinoma. The artical will provide an overview of how DNA methylation contribute to thyroid carcinoma dissemination,invasion and metastasis and we will summarize the latest epigenetic therapies for thyroid carcinoma.
Insights
Epigenetic modifications, specifically DNA methylation, play a key role in thyroid carcinoma development and spread. Reversing these changes offers a promising new treatment strategy for this cancer.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer development involves genetic and epigenetic factors.
- Epigenetic changes, like DNA methylation, alter gene expression without changing DNA sequence.
- Thyroid carcinoma is a significant health concern where epigenetic dysregulation is implicated.
Purpose of the Study:
- To explore the role of DNA methylation in thyroid carcinoma.
- To understand how DNA methylation contributes to cancer invasion and metastasis.
- To review current epigenetic therapies for thyroid carcinoma.
Main Methods:
- Literature review of studies on DNA methylation and thyroid carcinoma.
- Analysis of epigenetic mechanisms in cancer progression.
- Summary of emerging epigenetic treatment strategies.
Main Results:
- DNA methylation is a critical epigenetic modification influencing gene expression in thyroid carcinoma.
- Aberrant DNA methylation patterns are linked to tumor dissemination, invasion, and metastasis.
- Epigenetic therapies targeting DNA methylation show potential for treating thyroid carcinoma.
Conclusions:
- DNA methylation is a key driver in thyroid carcinoma progression.
- Targeting DNA methylation represents a viable therapeutic avenue for thyroid cancer.
- Further research into epigenetic therapies is crucial for effective thyroid carcinoma treatment.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Abnormal Proliferation
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

